Local Qualified Person for Pharmacovigilance (LQPPV)
Our Local QPPV Services: Scope and Deliverables
End-to-End Pharmacovigilance Oversight
Local Safety Intelligence and Signal Escalation
24/7 Availability and Regulatory Contact Point Duties
Support with RMP, PSMF Maintenance, and PV Audits
Benefits of Choosing a SaaS-Enabled Local QPPV Model
Qualified local expertise under expert supervision
Centralized oversight for consistent country-level PV and drug safety, providing scalable solutions for pharma companies in regulated markets
Improved visibility of safety activities and adverse events, supporting patient safety
Structured compliance for marketing authorization holders
Expert-controlled operations monitored continuously, supporting your local PV strategy
Adaptive system refined by PV specialists
How Our Platform Supports Local QPPV Operations
Automated Case Intake and Processing
The system collects updates from all connected health authority websites.
Integrated PSMF and SOP Management
Centralized PSMF, SOP, and additional medical information management ensure traceability and alignment between local qualified persons for pharmacovigilance and global pharmacovigilance systems.
Audit-Ready Documentation
Workflow: How We Deliver Local QPPV Services
Why Choose Us as Your Partner
Certified Safety Experts with Global Experience
Our team includes medically qualified professionals with extensive experience in local regulations and country-specific PV requirements.
Proven Technology in Pharmacovigilance Operations
DrugCard platform supports local pharmacovigilance operations, integrating case processing, PSMF, SOP management, and regulatory intelligence for audit-ready compliance.
How Fast Can Services Be Activated?
Local PV services can typically be established within weeks, providing immediate support for compliance and patient safety.
Frequently Asked Questions (FAQ)
The LQPPV operates in coordination with the EU QPPV, ensuring country-level pharmacovigilance activities are aligned with global safety governance, escalation pathways, and oversight expectations.
The LQPPV acts as the single point of contact during inspections, supports communication with national competent authorities, and ensures immediate access to required pharmacovigilance documentation.
Yes. The SaaS-enabled model enables centralized oversight while preserving local execution, supporting global consistency across markets with differing regulatory requirements. This scalability is built on proven strategies for managing pharmacovigilance activities across multiple countries and regulatory jurisdictions.
DrugCard supports quality through controlled workflows, documented procedures, and real-time reporting aligned with established regulatory standards. Expert oversight ensures consistent quality management across pharmacovigilance operations, even in diverse regulatory environments.
Accountability remains clearly defined between the marketing authorization holder, the EU QPPV, and the QPPV. Clearly documented roles, responsibilities, and oversight models support maintaining compliance with both local requirements and international regulations.
- Book a meeting for the demonstraion
- Anwers your additional questions
- Implenetation DrugCard to your pharmacovigilance system
- Tariff plans, pricing, addional features